Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds

被引:239
作者
Caruana, Mario [1 ]
Hoegen, Tobias [2 ]
Levin, Johannes [2 ]
Hillmer, Andreas [3 ]
Giese, Armin [3 ]
Vassallo, Neville [1 ]
机构
[1] Univ Malta, Dept Physiol & Biochem, Msida 2080, Msd, Malta
[2] Univ Munich, Klinikum Grosshadern, Neurol Klin, D-81377 Munich, Germany
[3] Univ Munich, Zentrum Neuropathol & Prionforsch, D-81377 Munich, Germany
关键词
Parkinson's disease; Alpha-synuclein; Aggregation; Confocal fluorescence spectroscopy; Polyphenol; Aromatic interaction; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; EPIGALLOCATECHIN-3-GALLATE EGCG; ANTIOXIDANT ACTIVITY; FLAVONOID BAICALEIN; GREEN TEA; IN-VITRO; FIBRILLATION; FIBRILS; BETA;
D O I
10.1016/j.febslet.2011.03.046
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Aggregation of alpha-synuclein (alpha S) into oligomers is critically involved in the pathogenesis of Parkinson's disease (PD). Using confocal single-molecule fluorescence spectroscopy, we have studied the effects of 14 naturally-occurring polyphenolic compounds and black tea extract on alpha S oligomer formation. We found that a selected group of polyphenols exhibited potent dose-dependent inhibitory activity on alpha S aggregation. Moreover, they were also capable of robustly disaggregating pre-formed alpha S oligomers. Based upon structure-activity analysis, we propose that the key molecular scaffold most effective in inhibiting and destabilizing self-assembly by alpha S requires: (i) aromatic elements for binding to the alpha S monomer/oligomer and (ii) vicinal hydroxyl groups present on a single phenyl ring. These findings may guide the design of novel therapeutic drugs in PD. Structured summary of protein interactions: Alpha-synuclein binds to Alpha-synuclein by biophysical (View Interaction 1, 2) (C) 2011 Federation of European Biochemical Societies. Published by Elsevier B. V. All rights reserved.
引用
收藏
页码:1113 / 1120
页数:8
相关论文
共 40 条
[1]   Analysis of flavonoids and other phenolic compounds using high-performance liquid chromatography with coulometric array detection: Relationship to antioxidant activity [J].
Aaby, K ;
Hvattum, E ;
Skrede, G .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2004, 52 (15) :4595-4603
[2]   Inhibitors of α-synuclein oligomerization and toxicity:: a future therapeutic strategy for Parkinson's disease and related disorders [J].
Amer, Dena A. M. ;
Irvine, G. Brent ;
El-Agnaf, Omar M. A. .
EXPERIMENTAL BRAIN RESEARCH, 2006, 173 (02) :223-233
[3]  
Baum L, 2004, J ALZHEIMERS DIS, V6, P367
[4]   Natural polyphenols as inhibitors of amyloid aggregation. Molecular dynamics study of GNNQQNY heptapeptide decamer [J].
Berhanu, Workalemahu M. ;
Masunov, Artem E. .
BIOPHYSICAL CHEMISTRY, 2010, 149 (1-2) :12-21
[5]   EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity [J].
Bieschke, Jan ;
Russ, Jenny ;
Friedrich, Ralf P. ;
Ehrnhoefer, Dagmar E. ;
Wobst, Heike ;
Neugebauer, Katja ;
Wanker, Erich E. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (17) :7710-7715
[6]   Full length α-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects [J].
Borghi, R ;
Marchese, R ;
Negro, A ;
Marinelli, L ;
Forloni, G ;
Zaccheo, D ;
Abbruzzese, G ;
Tabaton, M .
NEUROSCIENCE LETTERS, 2000, 287 (01) :65-67
[7]   Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid [J].
Conway, KA ;
Harper, JD ;
Lansbury, PT .
BIOCHEMISTRY, 2000, 39 (10) :2552-2563
[8]   Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct [J].
Conway, KA ;
Rochet, JC ;
Bieganski, RM ;
Lansbury, PT .
SCIENCE, 2001, 294 (5545) :1346-1349
[9]   Different species of α-synuclein oligomers induce calcium influx and seeding [J].
Danzer, Karin M. ;
Haasen, Dorothea ;
Karow, Anne R. ;
Moussaud, Simon ;
Habeck, Matthias ;
Giese, Armin ;
Kretzschmar, Hans ;
Hengerer, Bastian ;
Kostka, Marcus .
JOURNAL OF NEUROSCIENCE, 2007, 27 (34) :9220-9232
[10]   EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers [J].
Ehrnhoefer, Dagmar E. ;
Bieschke, Jan ;
Boeddrich, Annett ;
Herbst, Martin ;
Masino, Laura ;
Lurz, Rudi ;
Engemann, Sabine ;
Pastore, Annalisa ;
Wanker, Erich E. .
NATURE STRUCTURAL & MOLECULAR BIOLOGY, 2008, 15 (06) :558-566